Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

32.380
-1.540-4.54%
Volume:8.71M
Turnover:288.94M
Market Cap:196.35B
PE:29.74
High:34.560
Open:34.040
Low:32.360
Close:33.920
52wk High:43.587
52wk Low:27.658
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.28
T/O Rate:0.14%
Dividend:0.49
Dividend Rate:1.50%
EPS(LYR):1.089
ROE:19.40%
ROA:9.08%
PB:4.44
PE(LYR):29.74
PS:10.55

Loading ...

Hansoh Pharmaceutical - Risvutatug Rezetecan for Injection Included in Nmpa Priority Review for Small Cell Lung Cancer

THOMSON REUTERS
·
Sep 11

Movement Alert|HANSOH PHARMA Falls 3.06% in Regular Trading, Post-Earnings Rally Continues to Retrace Amid Sector Weakness

Market Focus
·
Sep 11

Hansoh Pharmaceutical Group Stock Falls 4.2% in Hong Kong

Dow Jones
·
Sep 10

Movement Alert|HANSOH PHARMA Falls 3.22% in Regular Trading, Pharmaceutical Sector Under Broad Pressure as Post-Earnings Rally Continues to Retrace

Market Focus
·
Sep 10

Hansoh Pharmaceutical Group Stock Falls 3.5% in Hong Kong

Dow Jones
·
Sep 09

UBS: Mixed First-Half Results for Chinese Pharma Stocks, Names Simcere as Top Pick

Stock News
·
Sep 09

Movement Alert|HANSOH PHARMA Falls 3.1% in Regular Trading, Broad Pharma Sector Selloff Drags Down Stock

Market Focus
·
Sep 09

CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points

Stock News
·
Sep 09

Hansoh Pharma Says China NMPA Accepts BLA for HS-20093 in Small Cell Lung Cancer

Reuters
·
Sep 07

One-Day Surge, Three-Day Slump: Can Hansoh Pharma's Shares Climb Back to HK$40?

Stock News
·
Sep 02

HANSOH PHARMA's Investigational ADC for Small Cell Lung Cancer Wins NMPA Filing Acceptance

Stock News
·
Sep 02

Hansoh Pharma Says China NMPA Accepts HS-20093 BLA for Small Cell Lung Cancer

Reuters
·
Sep 02

Hansoh Pharmaceutical Group Stock Climbs 2.2% in Hong Kong

Dow Jones
·
Sep 02

Hansoh Pharmaceutical Says NMPA Accepts Biologics License Application of HS-20093

Reuters
·
Sep 02

CLSA Lifts Hansoh Pharma Target Price to HK$43.70, Reaffirms Outperform Rating

Deep News
·
Sep 01

Movement Alert|HANSOH PHARMA Declines 3.28% in Regular Trading, Post-Earnings Profit-Taking Extends Amid Pharma Sector Weakness

Market Focus
·
Sep 01

JPMorgan Reaffirms 'Overweight' on Hansoh Pharma, Lifts Target Price to HK$50

Stock News
·
Aug 31

Hansoh Pharmaceutical Group Stock Sheds 3.8% in Hong Kong

Dow Jones
·
Aug 31

Movement Alert|HANSOH PHARMA Falls 3.16% in Regular Trading, Post-Earnings Profit-Taking Meets Broad Pharma Sector Weakness

Market Focus
·
Aug 31

Here's What Analysts Are Forecasting For Hansoh Pharmaceutical Group Company Limited (HKG:3692) After Its Half-Year Results

Simply Wall St.
·
Aug 29